Provided are conformable light delivery devices for increasing light penetration depth and related methods. The device comprises a tissue penetrating member having a distal end and a proximal end, the tissue penetrating member configured to penetrate the tissue of the patient to be inserted into the tissue, wherein the tissue penetrating member is at least partially optically transparent along a surface of the tissue penetrating member positioned between the distal end of the tissue penetrating member and the proximal end of the tissue penetrating member to provide optical transmission of at least a portion of the light through the surface of the tissue penetrating member, thereby allowing at least the portion of the light to be delivered into the tissue of the patient when the tissue penetrating member is inserted into the tissue; and a substrate that supports the tissue penetrating member.

A method and apparatus to provide phototherapy to companion animals. The apparatus includes at least one light source configured to flood illuminate inside a housing, a housing sized to surround at least one companion animal, and a control system to adjust the light flux and light duration of the at least one light source. The method includes providing said apparatus and flood illuminating at least one companion animal with a clinically significant light flux and light duration.

During a period of lack of use, a person risks muscle atrophy and/or otherwise losing muscle strength/functionality. During such a period of lack of user, a photoceutical can be applied to the person’s muscle(s) through a photoceutical medical device to decrease the occurrence of these risks. The photoceutical is specially configured to reduce these risks and includes at least one of a pulsed light signal, a continuous light signal, and a super-pulsed light signal.

A self-administrable system for improved immunity and treatment of respiratory tract infections in a subject, said system comprising: a configured irradiation unit for delivery of light energy into at least one portion of an in-vivo target selected from the group consisting of the thymus gland, sternal bone marrow and lungs.

Systems and methods are described for treatment of neurological conditions in which transcranial illumination using infrared, near-infrared and/or red wavelengths of light are delivered into the brain of a patient using a portable head wearable device. Systems and methods are also described to deliver light to patient tissues for photobiomodulation, particularly through the patient's mouth.

An apparatus for treating athlete's foot. The apparatus includes: a main body having at least one body accommodating space part to accommodate a body portion of at least one of a hand and foot; a laser output unit mounted onto the main body, and provided to emit laser light from an upper side to a lower side of the body accommodating space part; and a laser swing unit driven so that the laser output unit swings on the main body, in which the laser output unit includes a first laser diode emitting laser light of a 405 nm wavelength and a second laser diode emitting laser light of a 635 nm wavelength. The apparatus is capable of treating athlete's foot generated on the hand, foot, nails, or toenails by using the light from a laser and/or an LED having a wavelength band useful for treating athlete's foot.

A therapy system includes a therapy output device that includes light sources and a controller. The light sources are configured to output electromagnetic radiation at different peak wavelengths. The controller is configured to operate the light sources to output the electromagnetic radiation to differ between a first therapy program and second therapy program by at least one of peak wavelengths, irradiance of one or more of the peak wavelengths, or energy density of the one or more peak wavelengths.

In certain embodiments a light therapy system (e.g., phototherapy device), such as for treatment of Alzheimer's disease, depression, dementia, short-term memory, or for improved learning, improved athletic performance or improved cognitive performance, is provided where the light system comprises a blue light source that operates at a frequency in the range from 20 to 50 Hz (preferably around 40 Hz), whereby the system enables retinal ganglion cells of a human to be exposed in order to stimulate brain waves (gamma oscillations in the human's brain).

The present invention involves a programmable or static multiwavelength LED lighting fixture that is capable of emitting wavelengths of light both for visual perception and other key physiological processes. The lighting fixture produces emitted spectra, wherein one portion of the emitted spectra serves visual perception and at least one portion of the emitted spectra is selected from the group consisting of 290-315 nm; 360-400 nm; 470-490 nm; and 600-1400 nm.

A circadian rhythm entrainment platform can use medication circadian profiles that include mappings of medications to circadian rhythm disruptions and can make conversions of such circadian rhythm disruptions to administrations of light therapy to adjust for the disruptions. The circadian rhythm entrainment platform can specify how to entrain a patient's circadian rhythm using light therapy to compensate for or anticipate side effects of medications and for optimizing medication schedules for a patient's circadian rhythm so as to minimize side effects and increase medication effectiveness. The circadian rhythm entrainment platform can also gather information on the effects of medications on circadian rhythms and interact with patients, medical providers, and other providers in relation to light therapy.